DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Opioid antagonist
Opioid antagonist
Medications to Treat Opioid Use Disorder Research Report
Opioid Overdose – Use of Naloxone
1 Title Page Pharmacological Comparison of Mitragynine and 7
Naloxone FAQ What Is Naloxone?
Opioid Receptorsreceptors
ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
SAMHSA Opioid Overdose Prevention TOOLKIT
Are Opioid Antagonists Effective in Attenuating the Core Symptoms of Autism Spectrum Conditions in Children: a Systematic Review
Revex (Nalmefene Hydrochloride Injection) Rx Only DESCRIPTION REVEX (Nalmefene Hydrochloride Injection), an Opioid Antagonist, Is a 6-Methylene Analogue of Naltrexone
Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality
Ultra-Low-Dose Opioid Antagonists to Enhance Opioid Analgesia Paul Sloan, MD Scott Hamann, Phd, MD
TARGINIQ ER Safely and Effectively
National Judicial Opioid Task Force Treatment of Opioid Use Disorder
Use of Naloxone for the Prevention of Opioid Overdose Deaths
Medication for Addiction Treatment Guide
TENNESSEE DEPARTMENT of HEALTH OPIOID ANTAGONIST COLLABORATIVE PHARMACY PRACTICE POLICY Tennesseans Are Dying from Drug Overdose
Opioid Antagonist (Naltrexone) Modulation of Cerebellar Development: Histological and Morphometric Studies
OPIOID ANTAGONIST DRUG CLASS Movantik (Naloxegol) / Relistor (Methylnaltrexone Bromide) / Symproic (Naldemedine)
Top View
Coadministration of an Opioid Agonist and Antagonist for Pain Control
Truncated Mu Opioid Receptor Splice Variants As Targets for Powerful Pain Relief with Reduced Side Effects
Asymptomatic Celiac Disease Leo Pruimboom1,2* and Karin De Punder1,3
Antagonists in the Medical Management of Opioid Use Disorders: Historical and Existing Treatment Strategies
United States Patent (10) Patent No.: US 9,650,338 B1 Martirosyan (45) Date of Patent: May 16, 2017
2019 -- S 0409 Substitute a State of Rhode Island
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism Which Do Not Recruit
Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa Through Activation of Opioid Receptor System
Delta-Opioid Receptor
Guidelines for the Psychosocially Assisted Pharmacological Treatment
BUPRENORPHINE for Opioid Use Disorder
Embossable and Writable Multilaminate Backing
Preventing Opioid Overdose Deaths with Take-Home Naloxone
United States Patent (19) 11 Patent Number: 5,866,164 Kuczynski Et Al
National Practice Guideline
2018 Evidence-Based Strategies for Preventing Opioid Overdose
House of Representatives Staff Analysis Bill #: Cs/Hb
Undesignated Opioid Antagonist Report, School Year 2019-20